Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant988 active trials8 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01465659 | Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery | completed | Phase 1 / Phase 2 | 29 | Northwestern UniversityOTHER | 1 | Aug 5, 2021 | clinicaltrials |
| NCT03316599 | Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic Cancer | completed | Phase 1 | 26 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 3, 2021 |
| NCT04977596 | Related Studies of Imaging Features and Prognosis Between Pancreatic Neuroendocrine Tumors and Pancreatic Cancer | completed | — | 78 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jul 27, 2021 | clinicaltrials |
| NCT02546531 | Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer | completed | Phase 1 | 43 | Washington University School of MedicineOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT03003078 | A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane(PanCO) | completed | N/A | 50 | OncoSil Medical LimitedINDUSTRY | 3 | Jul 13, 2021 | clinicaltrials |
| NCT03076216 | A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel.(OncoPaC-1) | completed | N/A | 9 | OncoSil Medical LimitedINDUSTRY | 1 | Jul 13, 2021 | clinicaltrials |
| NCT04420039 | Plastic Stent Within a Lumen-Apposing Stent for Malignant Biliary Obstruction(LAMSpigBil) | completed | — | 39 | Hospital Universitari de BellvitgeOTHER | 1 | Jul 13, 2021 | clinicaltrials |
| NCT04954378 | Radiomics Based on Multimodal Imaging in Predicting Staging and Prognosis of Pancreatic Cancer | completed | — | 300 | Peking University Third HospitalOTHER | 0 | Jul 8, 2021 | clinicaltrials |
| NCT01104077 | Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN) | completed | — | 277 | Columbia UniversityOTHER | 1 | Jul 6, 2021 | clinicaltrials |
| NCT02550327 | Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer | completed | Early Phase 1 | 20 | Baylor Research InstituteOTHER | 1 | Jun 22, 2021 | clinicaltrials |
| NCT00438906 | Cancer of the Pancreas Screening Study (CAPS 3)(CAPS 3) | completed | — | 200 | Johns Hopkins UniversityOTHER | 1 | Jun 18, 2021 | clinicaltrials |
| NCT03189953 | 68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH(GLP-1-AHH) | completed | Phase 1 / Phase 2 | 56 | Radboud University Medical CenterOTHER | 0 | Jun 16, 2021 | clinicaltrials |
| NCT03188991 | Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms | completed | Phase 2 | 20 | NanOlogy, LLCINDUSTRY | 1 | Jun 14, 2021 | clinicaltrials |
| NCT00031694 | Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2021 | clinicaltrials |
| NCT01219829 | Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma | completed | — | 5 | Columbia UniversityOTHER | 1 | Jun 11, 2021 | clinicaltrials |
| NCT01027221 | Low Dose Radiation to Improve T-Cell Infiltration in Pancreatic Cancer(IMPACT2010) | completed | N/A | 32 | German Cancer Research CenterOTHER | 1 | Jun 10, 2021 | clinicaltrials |
| NCT02368860 | OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma(OXIRI) | completed | Phase 1 | 33 | National Cancer Centre, SingaporeOTHER | 1 | Jun 1, 2021 | clinicaltrials |
| NCT04724551 | The Neutrophil-to-Lymphocyte Ratio to Exclude Pancreatic Fistula(NLR) | completed | — | 648 | Institut Paoli-CalmettesOTHER | 0 | May 28, 2021 | clinicaltrials |
| NCT03599154 | Evaluation of GEMCITEST in Patients With Pancreatic Cancer and Treated by Chemotherapy(GEMCIPANC) | completed | — | 100 | Centre Georges Francois LeclercOTHER | 1 | May 24, 2021 | clinicaltrials |
| NCT03062124 | SpyGlass in Preoperative Diagnostics of Presumed Main Duct IPMNs: Efficacy and Novel Insights on Complications | completed | — | 101 | Helsinki University Central HospitalOTHER | 2 | May 20, 2021 | clinicaltrials |
| NCT01459614 | Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer | completed | Phase 2 | 44 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | May 19, 2021 | clinicaltrials |
| NCT04509492 | Role of EUS in Detection of Liver Metastasis | completed | — | 400 | Mahmoud WahbaOTHER | 1 | May 18, 2021 | clinicaltrials |
| NCT02716207 | Phase ǀ Study on Pancreatic Cancer Treated by CyberKnife | completed | N/A | 16 | Changhai HospitalOTHER | 1 | May 14, 2021 | clinicaltrials |
| NCT04660695 | Nasobiliary Drain Assisted EUS-guided Gastroenterostomies in Unresectable Malignant Gastric Outlet Obstruction(PENGUIN) | completed | — | 66 | Hospital del Rio HortegaOTHER | 2 | May 14, 2021 | clinicaltrials |
| NCT02237157 | A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer | completed | Phase 1 | 20 | RenovoRxINDUSTRY | 1 | May 7, 2021 | clinicaltrials |
| NCT02562898 | Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer | completed | Phase 1 / Phase 2 | 18 | Margaret TemperoOTHER | 1 | May 6, 2021 | clinicaltrials |
| NCT03205176 | AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas | completed | Phase 1 | 49 | AstraZenecaINDUSTRY | 2 | May 6, 2021 | clinicaltrials |
| NCT01077986 | Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer | completed | Phase 1 / Phase 2 | 35 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Apr 21, 2021 | clinicaltrials |
| NCT01210911 | Metformin Combined With Chemotherapy for Pancreatic Cancer(GEM) | completed | Phase 2 | 120 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Apr 21, 2021 | clinicaltrials |
| NCT02311361 | Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer | completed | Phase 1 / Phase 2 | 65 | National Cancer Institute (NCI)NIH | 1 | Apr 20, 2021 | clinicaltrials |
| NCT03352037 | 18F-FDG PET/MR Imaging for Differentiation of Serous From Non-Serous Pancreatic Cystic Neoplasms: A Pilot Study | completed | N/A | 11 | University Health Network, TorontoOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT02048384 | A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer | completed | Phase 1 | 22 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Apr 12, 2021 | clinicaltrials |
| NCT00521404 | Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic Cancer | completed | Phase 2 | 65 | Daiichi SankyoINDUSTRY | 1 | Apr 8, 2021 | clinicaltrials |
| NCT01251640 | Combination With Gemcitabine in Advanced Pancreatic Cancer(BAGPAC) | completed | Phase 1 / Phase 2 | 90 | BayerINDUSTRY | 9 | Apr 8, 2021 | clinicaltrials |
| NCT02155088 | BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer | completed | Phase 1 | 15 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT03222258 | Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients | completed | — | 444 | Seoul National University HospitalOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04802993 | Survival Among Patients With Pancreatic Cancer Depending on Surgical Resection Rate | completed | — | 5,123 | Linkoeping UniversityOTHER_GOV | 0 | Mar 17, 2021 | clinicaltrials |
| NCT02020252 | Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials | completed | — | 120 | University of ChicagoOTHER | 1 | Mar 10, 2021 | clinicaltrials |
| NCT03719716 | Early Support in Primary Care for People Starting Treatment for Cancer(GI-ACP) | completed | N/A | 46 | NHS LothianOTHER_GOV | 1 | Mar 9, 2021 | clinicaltrials |
| NCT00112658 | Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer | completed | Phase 2 / Phase 3 | 342 | UNICANCEROTHER | 1 | Mar 8, 2021 | clinicaltrials |
| NCT02154737 | Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer | completed | Phase 1 | 24 | Tony Reid, M.D., Ph.D.OTHER | 1 | Mar 2, 2021 | clinicaltrials |
| NCT00376948 | Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 20 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Mar 1, 2021 | clinicaltrials |
| NCT01838317 | A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas | completed | Phase 2 | 14 | University of Texas Southwestern Medical CenterOTHER | 1 | Mar 1, 2021 | clinicaltrials |
| NCT02055313 | Perceptions of Exceptional Patients in Cancer Care Relating to Their Unusual Survival | completed | — | 20 | Meir Medical CenterOTHER | 0 | Feb 25, 2021 | clinicaltrials |
| NCT02337465 | KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer | completed | N/A | 30 | Case Comprehensive Cancer CenterOTHER | 1 | Feb 23, 2021 | clinicaltrials |
| NCT04755036 | National Survey and Case-vignette Study of Clinical Decisions in Pancreatic Cancer(GECP01) | completed | — | 69 | Hospital Miguel ServetOTHER | 1 | Feb 15, 2021 | clinicaltrials |
| NCT03982446 | Germline Mutations in Pancreatic Adenocarcinoma(PaMPA) | completed | — | 549 | Hellenic Cooperative Oncology GroupOTHER | 1 | Feb 12, 2021 | clinicaltrials |
| NCT03415802 | Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer | completed | Phase 2 | 32 | Aiping ZhouUNKNOWN | 1 | Feb 1, 2021 | clinicaltrials |
| NCT04728750 | Laparoscopic Enucleation of Frantz's Tumor of the Pancreas | completed | — | 1 | Tecnologico de MonterreyOTHER | 1 | Jan 28, 2021 | clinicaltrials |
Data updated 24 days agoSource updated Aug 5, 2021source: clinicaltrials